Aquaporins -water channels in the cell membrane and therapeutic targets;Aquaporine: Wasserkanäle in der zellmembran und therapeutische zielstrukturen

Medizinische Monatsschrift fur Pharmazeuten

Volumn 36, Issue 3, 2013, Pages 86-94

  Von Bülow, Julia ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; WATER;

ARTICLE; CELL MEMBRANE; PATHOPHYSIOLOGY; PROTEIN STRUCTURE; WATER TRANSPORT; CHEMISTRY; DRUG EFFECT; GENETICS; HOMEOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW;

AQUAPORINS; CELL MEMBRANE; HOMEOSTASIS; HUMANS; WATER;

MLCS; MLOWN;

EID: 84879286519     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Baker N, Glover L, Munday JC, Aguinaga Andres D, et al. Aquaglyceroporin 2 controls susceptibility to melarsoprol and pentamidine in African trypanosomes. Proc Natl Acad Sci 2012;109:10 996-1001.
2. Baum BJ, Alevizos I, Zheng C, Cotrim AP, et al. Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiationinduced salivary hypofunction. Proc Natl Acad Sci 2012;109:19 403-7.
3. Beitz E. Aquaporins from pathogenic protozoan parasites: structure, function and potential for chemotherapy. Biol Cell 2005;97:373-83.
4. Beitz E. Aquaporin water and solute channels from malaria parasites and other pathogenic protozoa. Chem Med Chem 2006;1:587-92.
5. Bhattacharjee H, Rosen BP, Mukhopadhyay R. Aquaglyceroporins and metalloid transport: Implications in human diseases. In: Beitz E, editor. Aquaporins. Handb Exp Pharmacol 2009;(190):309-25.
6. Bolstad AI, Jonsson R. Gene therapeutics in Sjögren's syndrome. Expert Opin Biol Ther 2005;5:763-72.
7. Bülow Jv, Müller-Lucks A, Kai L, Bernhard F, et al. Functional characterization of a novel aquaporin from Dictyostelium discoideum amoebae implies a unique gating mechanism. J Biol Chem 2012;287:7487-94.
8. Eckhard A, Gleiser C, Arnold H, Rask-Andersen H, et al. Water channel proteins in the inner ear and their link to hearing impairment and deafness. Mol Aspects Med 2012;33:612-37.
9. Groot BL de, Hub JS. A Decade of debate: significance of CO2 permeation through membrane channels still controversial. ChemPhysChem 2011;12:1021-2.
10. Grünfeld J, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol 2009;5:270-6.
11. Hara-Chikuma M, Sohara E, Rai T, Ikawa M, et al. Progressive adipocyte hypertrophy in aquaporin-7-deficient mice: adipocyte glycerol permeability as a novel regulator of fat accumulation. J Biol Chem 2005;280:15 493-6.
12. Hara-Chikuma M, Verkman AS. Roles of aquaporin-3 in the epidermis. J Investig Dermatol 2008;128:2145-51.
13. Huber VJ, Tsujita M, Nakada T. Identification of aquaporin 4 inhibitors using in vitro and in silico methods. Bioorgan Med Chem 2009;17:411-7.
14. Huber VJ, Tsujita M, Nakada T. Aquaporins in drug discovery and pharmacotherapy. Mol Aspects Med 2012;33:691-703.
15. Jeyaseelan K, Sepramaniam S, Armugam A, Wintour EM. Aquaporins: a promising target for drug development. Expert Opin Ther Targets 2006;10:889-909.
16. King LS, Kozono D, Agre P. From structure to disease: the evolving tale of aquaporin biology. Nat Rev Mol Cell Biol 2004;5:687-98.
17. Maeda N, Funahashi T, Shimomura I. Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9. Nat Clin Pract Endocrinol Metab 2008;4:627-34.
18. Maekawa C, Kitahara T, Kizawa K, Okazaki S, et al. Expression and translocation of aquaporin-2 in the endolymphatic sac in patients with Meniere's disease. J. Neuroendocrinol 2010;22:1157-64.
19. Mola MG, Nicchia GP, Svelto M, Spray DC, et al. Automated cell-based assay for screening of aquaporin inhibitors. Anal Chem 2009;81:8219-29.
20. Morishita Y, Matsuzaki T, Hara-Chikuma M, Andoo A, et al. Disruption of aquaporin-11 produces polycystic kidneys following vacuolization of the proximal tubule. Mol Cell Biol 2005;25:7770-9.
21. Papadopoulos MC, Saadoun S, Verkman AS. Aquaporins and cell migration. Pflugers Arch 2008;456:693-700.
22. Parent CA. Making all the right moves: chemotaxis in neutrophils and Dictyostelium. Curr Opin Cell Biol 2004;16:4-13.
23. Pavlovic-Djuranovic S, Kun JFJ, Schultz JE, Beitz E. Dihydroxyacetone and methylglyoxal as permeants of the Plasmodium aquaglyceroporin inhibit parasite proliferation. Biochim Biophys Acta 2006;1758:1012-7.
24. Preston GM, Carroll TP, Guggino WB, Agre P. Appearance of water channels in Xenopus oocytes expressing red cell CHIP28 protein. Science 1992;256(5055):385-7.
25. Ratelade J, Verkman A. Neuromyelitis optica: aquaporin-4 based pathogenesis mechanisms and new therapies. Int J Biochem Cell B 2012;44:1519-30.
26. Sasaki S. Aquaporin 2: from its discovery to molecular structure and medical implications. Mol Aspects Med 2012;33:535-46.
27. Seeliger D, Zapater C, Krenc D, Haddoub R, et al. Discovery of novel human aquaporin-1 blockers. ACS Chem Biol 2013;8:249-56.
28. Sui H, Han BG, Lee JK, Walian P, et al. Structural basis of water-specific transport through the AQP1 water channel. Nature 2001;414(6866):872-8.
29. Takeda T, Taguchi D. Aquaporins as potential drug targets for Meniere's disease and its related diseases. In: Beitz E, editor. Aquaporins. Handb Exp Pharmacol 2009;(190):171-84.
30. Törnroth-Horsefield S, Hedfalk K, Fischer G, Lindkvist-Petersson K, et al. Structural insights into eukaryotic aquaporin regulation. FEBS Letters 2010;584:2580-8.
31. Trigueros-Motos L, Pérez-Torras S, Casado F, Molina-Arcas M, et al. Aquaporin 3 (AQP3) participates in the cytotoxic response to nucleoside-derived drugs. BMC Cancer 2012;12:434.
32. Verkman A. Aquaporins in clinical medicine. Annu Rev Med 2012;63:303-16.
33. Verkman AS. Aquaporins at a glance. J Cell Sci 2011;124:2107-12.
34. Verkman AS, Hara-Chikuma M, Papadopoulos MC. Aquaporins -new players in cancer biology. J Mol Med 2008;86:523-9.
35. Verkman AS, Ruiz-Ederra J, Levin MH. Functions of aquaporins in the eye. Prog Retin Eye Res 2008;27:420-33.
36. Walz T, Smith BL, Agre P, Engel A. The three-dimensional structure of human erythrocyte aquaporin CHIP. EMBO J 1994;13:2985-93.
37. Yang B, Ma T, Dong JY, Verkman AS. Partial correction of the urinary concentrating defect in aquaporin-1 null mice by adenovirus-mediated gene delivery. Hum Gene Ther 2000;11:567-75.
38. Yasui M, Hazama A, Kwon TH, Nielsen S, et al. Rapid gating and anion permeability of an intracellular aquaporin. Nature 1999;402(6758):184-7.
39. Zhang D, Vetrivel L, Verkman AS. Aquaporin deletion in mice reduces intraocular pressure and aqueous fluid production. J Gen Physiol 2002;119:561-9.